Corning 1 g Ciprofloxacin Hydrochloride, Powder 61-277-RF
Corning -- Item TECPIM000114985
Please add to cart & request for quote to see the price
Longer Lead Time
The Corning Mediatech 1 g Ciprofloxacin Hydrochloride, Powder 61-277-RF is a laboratory reagent specifically designed for in vitro research use. It is a fluoroquinolone antibiotic used for the treatment of infections caused by susceptible strains of bacteria.
Benefits/Advantages:
• Effective Broad-Spectrum Antibiotic: Ciprofloxacin hydrochloride is a synthetic antibiotic that demonstrates a broad spectrum of activity against various bacteria, making it an essential tool in antimicrobial susceptibility testing and bacterial culture.
• Inhibits Bacterial DNA Replication: By targeting and inhibiting bacterial DNA gyrase and topoisomerase IV enzymes, ciprofloxacin hydrochloride hinders bacterial DNA replication and repair, aiding in the study of bacterial molecular biology.
• Versatile Research Tool: This powder form of ciprofloxacin hydrochloride allows for easy customization of concentration and application, making it suitable for various research applications in the fields of microbiology, pharmacology, and molecular biology.
Product Details
| Model | |
|---|---|
| Product Type | Consumables |
| Part Number | 61-277-RF |
| Brand | Corning |
| Gross Dimensions (WxDxH cm) | |
| Net Dimensions (WxDxH cm) | |
| Gross Weight (kg) | |
| Net Weight (kg) |
| Size | 1 g |
|---|---|
| Storage Temperature | 15°C to 30°C |
Corning
For nearly 170 years, Corning has applied its unparalleled expertise in glass science, ceramic science, and optical physics to develop products that transform industries and enhance people’s lives. As a leading provider of consumable laboratory products for the research, bioproduction, and diagnostics markets, Corning provides high-quality, innovative products to researchers around the world to make and deliver life-changing discoveries.
Today, Corning's markets include optical communications, mobile consumer electronics, display, automotive, and life sciences.